annual total liabilities:
$45.34M+$8.88M(+24.36%)Summary
- As of today (June 29, 2025), CLDX annual total liabilities is $45.34 million, with the most recent change of +$8.88 million (+24.36%) on December 31, 2024.
- During the last 3 years, CLDX annual total liabilities has risen by +$20.16 million (+80.06%).
- CLDX annual total liabilities is now -61.56% below its all-time high of $117.93 million, reached on December 31, 2016.
Performance
CLDX Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$36.49M-$8.85M(-19.51%)Summary
- As of today (June 29, 2025), CLDX quarterly total liabilities is $36.49 million, with the most recent change of -$8.85 million (-19.51%) on March 31, 2025.
- Over the past year, CLDX quarterly total liabilities has increased by +$6.26 million (+20.69%).
- CLDX quarterly total liabilities is now -69.06% below its all-time high of $117.93 million, reached on December 31, 2016.
Performance
CLDX quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CLDX Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.4% | +20.7% |
| 3 y3 years | +80.1% | +40.7% |
| 5 y5 years | +56.8% | +26.7% |
CLDX Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +80.1% | -19.5% | +67.6% |
| 5 y | 5-year | at high | +80.1% | -19.5% | +67.6% |
| alltime | all time | -61.6% | +2733.4% | -69.1% | +2706.9% |
CLDX Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $36.49M(-19.5%) |
| Dec 2024 | $45.34M(+24.4%) | $45.34M(+21.6%) |
| Sep 2024 | - | $37.27M(+16.7%) |
| Jun 2024 | - | $31.93M(+5.6%) |
| Mar 2024 | - | $30.23M(-17.1%) |
| Dec 2023 | $36.46M(+37.4%) | $36.46M(+8.7%) |
| Sep 2023 | - | $33.54M(+54.0%) |
| Jun 2023 | - | $21.77M(-0.0%) |
| Mar 2023 | - | $21.78M(-17.9%) |
| Dec 2022 | $26.53M(+5.4%) | $26.53M(+11.4%) |
| Sep 2022 | - | $23.81M(-37.1%) |
| Jun 2022 | - | $37.87M(+46.0%) |
| Mar 2022 | - | $25.94M(+3.0%) |
| Dec 2021 | $25.18M(-4.9%) | $25.18M(+7.2%) |
| Sep 2021 | - | $23.49M(+5.5%) |
| Jun 2021 | - | $22.27M(-10.6%) |
| Mar 2021 | - | $24.90M(-6.0%) |
| Dec 2020 | $26.48M(-8.4%) | $26.48M(+2.7%) |
| Sep 2020 | - | $25.80M(+12.4%) |
| Jun 2020 | - | $22.96M(-20.3%) |
| Mar 2020 | - | $28.80M(-0.4%) |
| Dec 2019 | $28.91M(-9.0%) | $28.91M(-5.1%) |
| Sep 2019 | - | $30.46M(-6.6%) |
| Jun 2019 | - | $32.62M(-6.5%) |
| Mar 2019 | - | $34.88M(+9.9%) |
| Dec 2018 | $31.75M(-59.9%) | $31.75M(-20.9%) |
| Sep 2018 | - | $40.15M(-20.2%) |
| Jun 2018 | - | $50.33M(-12.2%) |
| Mar 2018 | - | $57.29M(-27.7%) |
| Dec 2017 | $79.25M(-32.8%) | $79.25M(-21.0%) |
| Sep 2017 | - | $100.27M(-12.5%) |
| Jun 2017 | - | $114.61M(+2.1%) |
| Mar 2017 | - | $112.21M(-4.8%) |
| Dec 2016 | $117.93M(+148.4%) | $117.93M(+238.3%) |
| Sep 2016 | - | $34.85M(-4.5%) |
| Jun 2016 | - | $36.50M(-12.9%) |
| Mar 2016 | - | $41.90M(-11.8%) |
| Dec 2015 | $47.48M(+30.6%) | $47.48M(+39.6%) |
| Sep 2015 | - | $34.01M(-8.9%) |
| Jun 2015 | - | $37.34M(+16.1%) |
| Mar 2015 | - | $32.15M(-11.6%) |
| Dec 2014 | $36.35M(+33.2%) | $36.35M(+12.6%) |
| Sep 2014 | - | $32.29M(+0.0%) |
| Jun 2014 | - | $32.28M(+20.2%) |
| Mar 2014 | - | $26.85M(-1.6%) |
| Dec 2013 | $27.30M(-8.3%) | $27.30M(+12.8%) |
| Sep 2013 | - | $24.21M(+26.5%) |
| Jun 2013 | - | $19.14M(-35.0%) |
| Mar 2013 | - | $29.42M(-1.2%) |
| Dec 2012 | $29.77M(+1.7%) | $29.77M(+3.3%) |
| Sep 2012 | - | $28.82M(+4.5%) |
| Jun 2012 | - | $27.58M(-4.4%) |
| Mar 2012 | - | $28.85M(-1.4%) |
| Dec 2011 | $29.27M(-15.6%) | $29.27M(+5.4%) |
| Sep 2011 | - | $27.77M(+4.9%) |
| Jun 2011 | - | $26.47M(-0.6%) |
| Mar 2011 | - | $26.62M(-23.3%) |
| Dec 2010 | $34.69M(-47.9%) | $34.69M(-42.0%) |
| Sep 2010 | - | $59.79M(-2.9%) |
| Jun 2010 | - | $61.57M(-3.8%) |
| Mar 2010 | - | $63.99M(-3.9%) |
| Dec 2009 | $66.60M(+28.9%) | $66.60M(+32.3%) |
| Sep 2009 | - | $50.34M(+0.5%) |
| Jun 2009 | - | $50.11M(-3.1%) |
| Mar 2009 | - | $51.69M(+0.1%) |
| Dec 2008 | $51.66M(+391.7%) | $51.66M(-6.7%) |
| Sep 2008 | - | $55.35M(-2.7%) |
| Jun 2008 | - | $56.91M(+350.2%) |
| Mar 2008 | - | $12.64M(+20.3%) |
| Dec 2007 | $10.51M(-82.3%) | $10.51M(-81.7%) |
| Sep 2007 | - | $57.35M(-1.2%) |
| Jun 2007 | - | $58.04M(+0.6%) |
| Mar 2007 | - | $57.71M(-2.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $59.32M(+281.2%) | $59.32M(+5.3%) |
| Sep 2006 | - | $56.35M(+1.1%) |
| Jun 2006 | - | $55.75M(+1.1%) |
| Mar 2006 | - | $55.12M(+254.2%) |
| Dec 2005 | $15.56M(+110.4%) | $15.56M(+1.2%) |
| Sep 2005 | - | $15.38M(-0.3%) |
| Jun 2005 | - | $15.43M(+136.9%) |
| Mar 2005 | - | $6.51M(-12.0%) |
| Dec 2004 | $7.40M(+118.5%) | $7.40M(+78.0%) |
| Sep 2004 | - | $4.15M(+24.8%) |
| Jun 2004 | - | $3.33M(+13.2%) |
| Mar 2004 | - | $2.94M(-13.1%) |
| Dec 2003 | $3.39M(-12.9%) | $3.39M(+4.2%) |
| Sep 2003 | - | $3.25M(-20.2%) |
| Jun 2003 | - | $4.07M(-1.2%) |
| Mar 2003 | - | $4.12M(+5.9%) |
| Dec 2002 | $3.89M(-52.7%) | $3.89M(+3.0%) |
| Sep 2002 | - | $3.78M(-46.3%) |
| Jun 2002 | - | $7.04M(-4.1%) |
| Mar 2002 | - | $7.34M(-10.7%) |
| Dec 2001 | $8.22M(-14.7%) | $8.22M(+2.2%) |
| Sep 2001 | - | $8.04M(-7.0%) |
| Jun 2001 | - | $8.64M(+10.3%) |
| Mar 2001 | - | $7.83M(-18.7%) |
| Dec 2000 | $9.63M(+290.0%) | $9.63M(+67.4%) |
| Sep 2000 | - | $5.75M(+18.2%) |
| Jun 2000 | - | $4.87M(-10.3%) |
| Mar 2000 | - | $5.43M(+119.7%) |
| Dec 1999 | $2.47M(-35.9%) | $2.47M(+2.9%) |
| Sep 1999 | - | $2.40M(-14.3%) |
| Jun 1999 | - | $2.80M(-24.3%) |
| Mar 1999 | - | $3.70M(-3.9%) |
| Dec 1998 | $3.85M(+10.0%) | $3.85M(-3.7%) |
| Sep 1998 | - | $4.00M(+48.1%) |
| Jun 1998 | - | $2.70M(-10.0%) |
| Mar 1998 | - | $3.00M(-14.3%) |
| Dec 1997 | $3.50M(+118.8%) | $3.50M(-7.9%) |
| Sep 1997 | - | $3.80M(+171.4%) |
| Jun 1997 | - | $1.40M(+7.7%) |
| Mar 1997 | - | $1.30M(-18.8%) |
| Dec 1996 | $1.60M(-36.0%) | $1.60M(+23.1%) |
| Sep 1996 | - | $1.30M(-13.3%) |
| Jun 1996 | - | $1.50M(-21.1%) |
| Mar 1996 | - | $1.90M(-24.0%) |
| Dec 1995 | $2.50M(-19.4%) | $2.50M(+25.0%) |
| Sep 1995 | - | $2.00M(-13.0%) |
| Jun 1995 | - | $2.30M(-17.9%) |
| Mar 1995 | - | $2.80M(-9.7%) |
| Dec 1994 | $3.10M(-22.5%) | $3.10M(-31.1%) |
| Sep 1994 | - | $4.50M(+9.8%) |
| Jun 1994 | - | $4.10M(-2.4%) |
| Mar 1994 | - | $4.20M(+5.0%) |
| Dec 1993 | $4.00M(+66.7%) | $4.00M(+37.9%) |
| Sep 1993 | - | $2.90M(+16.0%) |
| Jun 1993 | - | $2.50M(-7.4%) |
| Mar 1993 | - | $2.70M(-12.9%) |
| Dec 1992 | $2.40M(-29.4%) | - |
| Oct 1992 | - | $3.10M(-8.8%) |
| Jul 1992 | - | $3.40M(0.0%) |
| Apr 1992 | - | $3.40M(+21.4%) |
| Apr 1992 | $3.40M(+21.4%) | - |
| Jan 1992 | - | $2.80M(-3.4%) |
| Oct 1991 | - | $2.90M(+3.6%) |
| Jul 1991 | - | $2.80M(0.0%) |
| Apr 1991 | $2.80M(+12.0%) | $2.80M(+33.3%) |
| Jan 1991 | - | $2.10M(0.0%) |
| Oct 1990 | - | $2.10M(-32.3%) |
| Jul 1990 | - | $3.10M(+24.0%) |
| Apr 1990 | $2.50M(-47.9%) | $2.50M(+31.6%) |
| Jan 1990 | - | $1.90M(-60.4%) |
| Apr 1989 | $4.80M(+29.7%) | $4.80M(+29.7%) |
| Apr 1988 | $3.70M(-11.9%) | $3.70M(-11.9%) |
| Apr 1987 | $4.20M(-26.3%) | $4.20M(-26.3%) |
| Apr 1986 | $5.70M | $5.70M |
FAQ
- What is Celldex Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Celldex Therapeutics?
- What is Celldex Therapeutics annual total liabilities year-on-year change?
- What is Celldex Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly total liabilities year-on-year change?
What is Celldex Therapeutics annual total liabilities?
The current annual total liabilities of CLDX is $45.34M
What is the all time high annual total liabilities for Celldex Therapeutics?
Celldex Therapeutics all-time high annual total liabilities is $117.93M
What is Celldex Therapeutics annual total liabilities year-on-year change?
Over the past year, CLDX annual total liabilities has changed by +$8.88M (+24.36%)
What is Celldex Therapeutics quarterly total liabilities?
The current quarterly total liabilities of CLDX is $36.49M
What is the all time high quarterly total liabilities for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly total liabilities is $117.93M
What is Celldex Therapeutics quarterly total liabilities year-on-year change?
Over the past year, CLDX quarterly total liabilities has changed by +$6.26M (+20.69%)